Dr Ciara Conduit
Honorary Fellow
Department of Medical Biology (WEHI)
41 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma
DOI: 10.1016/j.annonc.2026.04.0052026
Journal article
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series
DOI: 10.1111/ajco.700832026
Journal article
Initial results from CLIMATE, a prospective cohort study assessing the clinical utility of miR-371a-3p (miR-371) as a marker of minimal residual disease (MRD) in clinical stage 1 testicular germ cell tumour (TGCT): ANZUP 1906.
DOI: 10.1200/JCO.2026.44.7_suppl.5862026
Journal article
Optimal Management of Stage II Seminoma: Preventing Harm While Preserving Cure
DOI: 10.1200/OP-25-002522026
Journal article
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies
DOI: 10.1177/175883592614218102026
Journal article
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review
DOI: 10.1080/14796694.2025.24757302025
Journal article
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours
DOI: 10.1002/bco2.70057
RECENT SCHOLARLY WORKS
2025
Journal article
Testicular cancer
DOI: 10.1016/S0140-6736(25)00455-62025
Journal article
An exploration of testicular cancer survivors’ experience of ejaculatory dysfunction following retroperitoneal lymph node dissection—a sub-study of the PREPARE clinical trial
DOI: 10.1007/s11764-023-01489-92025
Journal article
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
DOI: 10.1080/14796694.2024.2440277